Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Suhail Mithani

Plastic Surgery Durham, NC Medical Doctor

NPI 1629093109 CMS profile 495104

40 Duke Medicine Cir, Durham, NC 27710

Open in the dashboard

General payments

$146,182

227 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$216,552 paid to institutions, not to them · program years 2022–2024

Through program year 2025, Suhail Mithani of Durham, NC is reported in the CMS Open Payments database as having received $146,182 across 227 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $216,552 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,941 26
2024 General $14,176 26
2023 General $24,925 44
2022 General $19,032 24
2021 General $32,748 28
2020 General $18,698 15
2019 General $27,662 64

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Suhail Mithani
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Suhail Mithani were reported at $8,941. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Suhail Mithani Plastic Surgery median Middle half National median
2019 $27,662 $371 $122–$1,483 $163
2020 $18,698 $158 $52–$438 $114
2021 $32,748 $249 $87–$752 $132
2022 $19,032 $274 $102–$793 $149
2023 $24,925 $299 $113–$891 $160
2024 $14,176 $361 $124–$1,062 $164
2025 $8,941 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Integra LifeSciences Corporation $124,032 126 payments
  2. Derma Sciences, Inc. $7,762 7 payments
  3. AxoGen $4,646 5 payments
  4. Tulavi Therapeutics, Inc. $1,500 1 payment
  5. AbbVie, Inc. $1,475 20 payments
  6. TriMed, Inc. $1,459 4 payments
  7. Medartis Inc. $634 5 payments
  8. Musculoskeletal Transplant Foundation Inc. $569 7 payments
  9. Checkpoint Surgical, Inc $517 4 payments
  10. Allergan Inc. $353 7 payments
  11. Other $3,236 41 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $91,700 34 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $32,531 20 payments
  3. Travel and Lodging $10,508 49 payments
  4. Food and Beverage $9,482 120 payments
  5. Honoraria $1,500 1 payment
  6. Education $295 1 payment
  7. Entertainment $166 2 payments
Products named General payments · program years 2019–2025
  1. Integra Recon-Skin And Wound $36,657 34 payments
  2. Integra Recon-Skin And Wound $36,657 34 payments
  3. TENOGLIDE TENDON PROTECTOR SHEET $26,815 10 payments
  4. NEURAGEN NERVE GUIDE $26,815 10 payments
  5. FLOWABLE $21,684 26 payments
  6. BILAYER WOUND MATRIX (BWM) $21,684 26 payments
  7. INTEGRA WOUND MATRIX (IWM) $21,182 19 payments
  8. IDRT $21,182 19 payments
  9. TENOGLIDE $14,775 22 payments
  10. NEURAGEN $12,323 7 payments
  11. Other $124,806 295 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

19

Median for Orthopedic Surgery: 203

Drug cost

$47

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 19 $47

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 117 billing codes

Paid by Medicare

$124,520

Of which drugs: $1,826

Medicare patients

287

Average age 72

Services billed

1,332

172 women, 115 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 66%
Arthritis 65%
Diabetes 29%
Ischemic heart disease 25%
Depression 21%
Chronic kidney disease 20%
Osteoporosis 16%
Cancer 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 100 348 $1,826

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

227 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record